Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Protoplasma ; 254(2): 849-862, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27335008

ABSTRACT

In vitro antioxidant virtue and life-prolonging effect of phycoerythrin (PE; a pigment protein isolated from Phormidium sp. A09DM) have been revealed in our previous reports (Sonani et al. in Age 36:9717, 2014a; Sonani et al. in Process Biochem 49:1757-1766, 2014b). It has been hypothesized that the PE expands life span of Caenorhabditis elegans (bears large resemblance with human aging pathways) due to its antioxidant virtue. This hypothesis is tested in present study by checking the effect of PE on intracellular reactive oxygen species (ROS) generation and associated physiological deformities using mouse and human skin fibroblasts, C. elegans, and Drosophila melanogaster Oregon R + and by divulging PE's structural attributes responsible for its antioxidant asset. PE treatment displayed noteworthy decrease of 67, 48, and 77 % in ROS level in mouse fibroblast (3T3-L1), human fibroblast, and C. elegans N2, respectively, arisen under chemical-induced oxidative stress. PE treatment delayed the development of paraquat-induced Alzheimer phenotype by 14.5 % in C. elegans CL4176. Furthermore, PE improved the locomotion of D. melanogaster Oregon R + under oxidative stress with simultaneous up-regulation in super-oxide dismutase and catalase activities. The existence of 52 Glu + Asp + His + Thr residues (having metal ion sequestration capacity), 5 phycoerythrobilin chromophores (potential electron exchangers) in PE's primary structure, and significant hydrophobic patches on the surface of its α- and ß-subunits are supposed to collectively contribute in the antioxidant virtues of PE. Altogether, results support the hypothesis that it is the PE's antioxidant asset, which is responsible for its life-prolonging effect and thus could be exploited in the therapeutics of ROS-associated abnormalities including aging and neurodegeneration in eukaryotes.


Subject(s)
Eukaryota/drug effects , Eukaryota/metabolism , Intracellular Space/metabolism , Oxidative Stress/drug effects , Phycoerythrin/pharmacology , Reactive Oxygen Species/metabolism , 3T3-L1 Cells , Alzheimer Disease/pathology , Amyloid beta-Peptides/toxicity , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Caenorhabditis elegans/drug effects , Catalase/metabolism , Cell Survival/drug effects , Computer Simulation , Drosophila melanogaster/drug effects , Drosophila melanogaster/enzymology , Drosophila melanogaster/metabolism , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Hydrogen Peroxide/toxicity , Mice , Paraquat/toxicity , Phycoerythrin/chemistry , Phycoerythrin/isolation & purification , Phycoerythrin/metabolism , Protein Aggregation, Pathological , Superoxide Dismutase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...